Abstract
Immune related adverse events (irAEs) are one of the leading causes of discontinuation of cancer immunotherapy treatment. Despite extensive research into the frequency and types of irAEs, little is known about the cell types and pathways through which these drugs cause the observed side effects. To identify cell types and pathways of interest, we have analyzed single cell sequencing data of PBMCs from patients who developed skin irAEs as a result of their immunotherapy treatment. Using Azimuth’s cell type identification software for PBMCs and GSEA pathway analysis, we found macrophage cell populations and reactive oxygen species related pathways to be upregulated. These results provide important groundwork to build a complete picture of the mechanisms which cause irAEs and finding ways to more effectively treat them.
Original language | English (US) |
---|---|
Article number | 5407 |
Journal | Cancers |
Volume | 14 |
Issue number | 21 |
DOIs | |
State | Published - Nov 2022 |
Keywords
- autoimmunity
- cancer
- immune checkpoint blockade
- immune related adverse event
- immunotherapy
- inflammation
ASJC Scopus subject areas
- Oncology
- Cancer Research